Method of treating myocardial infarction with PDE-5 inhibitors
A method is provided for the prevention of ischemia/reperfusion injury, for example, in patients undergoing heart surgery, and involves the administration of a phosphodiesterase-5 (PDE-5) inhibitor such as sildenafil. The method may also be used during or after a heart attack to prevent or lessen ischemic heart damage.
1. A method of treating myocardial infarction caused by ischemic-reperfusion injury in a patient, comprising the step of administering to said patient in need thereof an effective amount of a composition consisting essentially of a phosphodiesterase-5 (PDE-5) inhibitor selected from the group consisting of sildenafil, vardenafil and tadalafil to reduce infarct size, wherein said effective amount is 5 mg or less.
2. A method of claim 1 wherein said step of administering is performed after said ischemic-reperfusion injury.
3. The method of claim 1 wherein said step of administering is via an intraperitoneal route.
4. The method of claim 1 wherein said step of administering is via an oral route.
5. The method of claim 1 wherein said step of administering is via an intravenous route.
6. The method of claim 1 wherein said step of administering is via an intracoronary route.
7. The method of claim 1 wherein said patient is a human.
8. The method of claim 1 wherein said patient is a non-human mammal.
9. The method of claim 1 wherein 1 mg or less of said PDE-5 inhibitor is administered.